Latest

CSOP Nikkei 225 -2x(07515.HK) +0.94%, Daiwa sees BOJ hold this month ] As of 10:47 HKT on Oct 26, 2026, CSOP Nikkei 225 -2x(07515.HK) rose 0.94% to HK$15.070; the ETF tracks the Nikkei 225 Index on a daily -2x inverse basis.
11:04
CSOP Nikkei 225 -2x07515.HKETF Intraday Move
GlobalX S&P Crude(03097.HK) +0.66%, IEA sees 2026 demand down 2.6m bpd ] As of 10:46 HKT on Oct 26, 2026, GlobalX S&P Crude Oil(03097.HK) rose 0.66% to HK$10.660; it tracks the S&P GSCI Crude Oil Enhanced ER Index; assets HK$102m.
10:55
GlobalX S&P Crude Oil03097.HKETF Intraday Move
iShares India(02836.HK) +0.71%, Infosys cuts FY27 revenue guidance ] As of 09:50 HKT on Oct 26, 2026, iShares India(02836.HK) rose 0.71% to HK$34.240; it tracks the S&P BSE SENSEX Index with HK$4.55 billion in net assets.
10:35
iShares India02836.HKETF Intraday Move
iShares MS Taiwan(03074.HK) +0.98%, Allianz sees 2027 profit up ~35% ] As of 10:18 HKT on Oct 26, 2026, iShares MS Taiwan(03074.HK) rose 0.98% to HK$464.500; the ETF tracks the MSCI Taiwan 20/35 Index with HK$938m in assets.
10:30
iShares MS Taiwan03074.HKETF Intraday Move
Kling 4.0 API Goes Live; Csop Hang Seng Tech Index Etf (03033.HK) Falls 1.42% Intraday ] On Oct 26, 2026, Csop Hang Seng Tech Index Etf (03033.HK) fell 1.42% to HK$3.744 on turnover of HK$1.45 billion, with AUM of HK$56.4 billion and NAV HK$3.7959.
10:04
ETFCSOP Hang Seng Tech Index ETF03033.HK
Chinese Innovative Drugs Set Record Share of ESMO Late-Breaking Abstracts; CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.81% Intraday ] As of October 26, 2026, CSOP Hang Seng Biotech ETF (03174.HK) rose 0.81% intraday to a latest price of HK$3.488, with a turnover of HK$364,800 and a turnover rate of 0.04%
09:50
ETFCSOP Hang Seng Biotech ETF03174.HK
Central SOE Market Value Management Advances; Bosera China Reform Hong Kong Central-Soes High Dividend Yield Index Etf(Listed Class) (03437.HK) Rises 1.07% Intraday ] As of October 26, 2026, Bosera China Reform Hong Kong Central-Soes High Dividend Yield Index Etf(Listed Class) (03437.HK) rose 1.07% intraday to a latest price of HK$9.420, with a turnover of HK$5.199 million and a turnover rate of 0.06%。
09:44
ETFBosera China Reform Hong Kong Central-Soes High Dividend Yield Index Etf(Listed Class)03437.HK
HAITONG UT (01905.HK): H Shares and Two Bonds Resume Trading at 9 am Today ] On 26 Oct 2026, an HKEX notice said HAITONG UT's (01905.HK) H shares and two bonds (84497, 85014) resume trading at 9 am that day, with no reason given.
09:18
NewTimeSpaceHAITONG UT01905.HK
HUTCHMED (00013.HK): SAFFRON Phase III Data at ESMO; Combination Cuts Progression Risk by 45% ] On 26 Oct 2026, HUTCHMED (00013.HK) said its SAFFRON trial met its PFS goal, with 7.6 vs 5.4 months (HR 0.55) in MET-driven EGFR-mutant NSCLC.
08:51
NewTimeSpaceHUTCHMED00013.HK
GENFLEET-B (02595.HK): First Clinical Data for Pan-RAS Inhibitor GFH276 Selected as ESMO LBA ] On 26 Oct 2026, GENFLEET-B (02595.HK) reported first-in-human GFH276 data at ESMO: ORR was 41.1% in 61 evaluable PDAC patients and 45.5% in 11 NSCLC patients.
08:35
NewTimeSpaceGENFLEET-B02595.HK
SBP GROUP (01177.HK): TQB2102 Data at ESMO; Phase III Breast Cancer Median PFS 16.4 Months ] On 26 Oct 2026, SBP GROUP (01177.HK) said TQB2102's Phase III APEX-Breast01 showed median PFS of 16.4 vs 5.5 months (HR 0.29) in HER2-low breast cancer.
08:29
NewTimeSpaceSBP GROUP01177.HK
CARSGEN-B (02171.HK): Phase Ib Results of CT041 Consolidation Therapy in Gastric Cancer Presented at ESMO ] On 26 Oct 2026, CARSGEN-B (02171.HK) said Phase Ib results of CT041 in gastric cancer were shown as an ESMO poster, without data being disclosed.
08:27
NewTimeSpaceCARSGEN-B02171.HK
ASCLETIS-B (01672.HK): IND for Oral Obesity Drug ASC39 Filed with US FDA ] On 26 Oct 2026, ASCLETIS-B (01672.HK) filed an IND with the US FDA for ASC39, an oral amylin agonist for obesity, with Phase I expected in Q4 2026.
08:21
NewTimeSpaceASCLETIS-B01672.HK
EB ENVIRONMENT (00257.HK): Consortium Wins Dongguan Waste-to-Energy Concession, Phase 1 Investment RMB2.25bn ] On 23 Oct 2026, EB ENVIRONMENT (00257.HK) said its consortium won a Dongguan waste-to-energy concession, with phase 1 investment of about RMB2.25bn.
08:15
NewTimeSpaceEB ENVIRONMENT00257.HK
SINOPHARM (01099.HK): Nine-Month Revenue RMB427.6bn, Net Profit Attributable RMB5.31bn ] On 23 Oct 2026, SINOPHARM (01099.HK) posted unaudited nine-month revenue of RMB427.61bn, down 0.89%; net profit RMB8.08bn and attributable profit RMB5.31bn.
08:14
NewTimeSpaceSINOPHARM01099.HK
MEITUAN-W (03690.HK): Proposes RMB Senior Notes to Refinance Offshore Debt ] On 26 Oct 2026, MEITUAN-W (03690.HK) proposed RMB senior notes to professional investors, with proceeds mainly to refinance offshore debt.
08:07
NewTimeSpaceMEITUAN-W03690.HK
BITFIRE GROUP (01611.HK): Digital Asset AUM Reaches US$221m, Up 60.1% QoQ ] On 26 Oct 2026, BITFIRE GROUP (01611.HK) reported digital asset AUM of about US$221m, up 60.1% QoQ, and quarterly crypto trading volume of US$342m, up 362.2%.
08:06
NewTimeSpaceBITFIRE GROUP01611.HK
AKESO (09926.HK): Phase III Results for Ivonescimab in First-Line Biliary Tract Cancer at ESMO ] On 26 Oct 2026, AKESO (09926.HK) said HARMONi-GI1 met its OS endpoint, with median OS of 14.9 vs 12.1 months in first-line biliary tract cancer.
07:42
NewTimeSpaceAKESO09926.HK
SHIMAO GROUP (00813.HK): Default Triggered as 60-Day Petition Period Expires ] On 26 Oct 2026, SHIMAO GROUP (00813.HK) said the 60-day period lapsed on 25 October, triggering defaults on offshore debt with about US$9.07bn outstanding.
07:14
NewTimeSpaceSHIMAO GROUP00813.HK
SHOUCHENG (00697.HK): Fund Invests in Huixi Intelligent, Betting on Embodied-AI Chips ] On 26 Oct 2026, SHOUCHENG (00697.HK) said a managed fund invested in Beijing embodied-AI chip developer Huixi Intelligent; no amount was disclosed.
07:05
NewTimeSpaceSHOUCHENG00697.HK
Previous1..1516 171819..607     607 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments